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Abstract The effect of phosphorylation in the N-terminal
region of myosin phosphatase target subunit 1 (MYPT1) on
the interactions with protein phosphatase 1 catalytic subunit
(PP1c) and with phosphorylated 20 kDa myosin light chain (P-
MLC20) was studied. Protein kinase C (PKC) phosphorylated
threonine-34 (1 mol/mol), the residue preceding the consensus
PP1c-binding motif (35KVKF38) in MYPT11ÿ38, but this did not
affect binding of the peptide to PP1c. PKC incorporated 2 mol Pi
into MYPT11ÿ296 suggesting a second site of phosphorylation
within the ankyrin repeats (residues 40^296). This phosphoryla-
tion diminished the stimulatory effect of MYPT11ÿ296 on the
P-MLC20 phosphatase activity of PP1c. Binding of PP1c or
P-MLC20 to phosphorylated MYPT11ÿ296 was also attenuated.
It is concluded that phosphorylation of MYPT1 by PKC may
therefore result in altered dephosphorylation of myosin. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
Key words: Myosin phosphatase; Protein phosphatase 1;
Myosin phosphatase target subunit 1; Protein kinase C;
Ankyrin repeat
1. Introduction
Phosphorylation of the 20 kDa light chains of smooth
muscle myosin (MLC20) has an essential regulatory function
in the contractile activity of smooth muscle and motile events
in non-muscle cells [1]. The phosphorylation level of myosin is
mediated by the activities of MLC20 kinase (MLCK) [2] and
myosin phosphatase (MP) [3]. There is renewed interest in the
role of MP since it was realized that MP could be regulated.
This occurs during Ca2-sensitization of many smooth
muscles in which contraction at low intracellular [Ca2] re-
£ects an inhibition of MP via a G-protein-linked mechanism
[4]. Smooth muscle MP is composed of three subunits : the
catalytic subunit of type 1 protein phosphatase (PP1c), the
110/133 kDa myosin binding (targeting) subunit, termed my-
osin phosphatase target subunit 1 (MYPT1), and a 20 kDa
protein [5,6]. MYPT1 appears to be an important component
for the regulation of MP and its interactions with proteins
and lipids. MYPT1 interacts with PP1c, a¡ecting substrate
speci¢city [7,8], and it binds to myosin [9^11] localizing the
enzyme to the contractile proteins. In addition, MYPT1 is
phosphorylated on Thr-695 (in the 133 kDa isoform) by
Rho-associated kinase and this results in the inhibition of
MP activity [12]. Other putative phosphorylation sites in
MYPT1 that increase MP activity [13] or a¡ect interaction
with phospholipids [14] have also been described.
The N-terminal half of MYPT1 binds to PP1c [7,8,15] and
this region of the molecule is also involved in binding to
myosin [9]. Residues 35^38 (KVKF) in MYPT1 correspond
to a consensus PP1c-binding sequence (K/R-I/V-X-F/W) iden-
ti¢ed in many PP1c-binding proteins [16]. Binding assays with
truncation mutants of MYPT1 established that the presence
of the PP1c-binding motif is essential for the interactions be-
tween PP1c and MYPT1 [7,15]. Using the surface plasmon
resonance (SPR) binding technique it was shown that the
interaction of PP1c with the 35KVKF38 sequence promoted
the binding of other regions of MYPT1, including sequences
1^22, 40^296 (ankyrin repeats) and 304^511 [15]. These data
suggested that subunit interactions between PP1c and MYPT1
develop in an ordered and cooperative manner. Interactions
with the N-terminal region of MYPT1 also in£uence the en-
zymatic properties of PP1c in a substrate-dependent manner.
The N-terminal peptide (residues 1^38) and the ankyrin re-
peats of MYPT1 stimulate the phosphorylated form of
MLC20 (P-MLC20) phosphatase activity of PP1c due to an
increase of Vmax and a decrease of Km, respectively [17].
P-MLC20 bound to truncation mutants of MYPT1 that in-
cluded the ankyrin repeats in overlay assays suggesting a
role for this region in increasing the a⁄nity of MP for the
myosin substrate [7]. In contrast, interaction of PP1c with the
ankyrin repeats resulted in e¡ective inhibition of its phosphor-
ylase phosphatase activity [8,15].
The interactions of PP1c with the glycogen targeting sub-
unit in skeletal muscle (GM) [18], the nuclear inhibitor of PP1
(NIPP1) [19] and neurabin [20] are modulated via phosphor-
ylation of Ser/Thr residues located close to or within the
PP1c-binding motif. The present study was undertaken to
examine whether phosphorylation of the N-terminal region
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in MYPT1 in£uences binding to PP1c and a¡ects PP1c activ-
ity with distinct substrates. Our results demonstrate that pro-
tein kinase C (PKC) phosphorylates the threonine residue
(Thr-34) that precedes the PP1c-binding motif. However,
this phosphorylation has no in£uence on the interaction of
the N-terminal MYPT1 fragments with PP1c. PKC also phos-
phorylates the ankyrin repeats and this results in modi¢cation
of the phosphatase activity and also reduced binding of
P-MLC20 to this region of MYPT1.
2. Materials and methods
2.1. Materials
Chemicals and vendors were as follows: [Q-32P]ATP (ICN Biomed-
icals), Q-Sepharose Fast Flow and chelate-Sepharose Fast Flow
(Pharmacia). Peptides corresponding to the MYPT1 sequences of res-
idues 1^38, 23^38 and 1^34 were synthesized by Macromolecular Re-
sources (Colorado State University, Fort Collins, CO, USA) coupling
an N-terminal cysteine residue to each peptide. All of the MYPT
peptides and mutants were based on the sequence of chicken gizzard
MYPT1 isoform [6]. Other chemicals were of the highest grade com-
mercially available.
2.2. Protein preparations
Rabbit skeletal muscle [32P]phosphorylase [21], turkey gizzard
[32P]MLC20 [22], PKC (a mixture of Ca2-dependent K, L and Q iso-
forms) from rat brain [23] and PP1c from rabbit skeletal muscle [15]
were prepared as described. Recombinant PP1cN (rPP1c) was ex-
pressed in Escherichia coli with a hexahistidine tag (His-tag) [24]
and, after renaturation [25], ¢nal puri¢cation was achieved by chro-
matography on Ni-agarose. His-tagged MYPT1ÿ296 was expressed [7],
renatured and puri¢ed using the same procedure as for rPP1c [25]. It
should be noted that the application of this renaturation process is
necessary to obtain recombinant MYPT1ÿ296 that stimulates P-
MLC20 phosphatase activity of PP1c and that can be phosphorylated
by PKC.
2.3. Phosphorylation of MYPT1 peptides
MYPT1 peptides (2^10 WM) were phosphorylated by PKC
(2 Wg/ml) at 30‡C in 20 mM HEPES/NaOH (pH 7.5) containing
mixed micelles (0.3 mg/ml L-K-phosphatidyl-L-serine, 0.062 mg/ml
1,2-diolein and 0.03% Triton X-100), 0.2 mM CaCl2, 10 mM DTT,
0.25 mM [Q-32P]ATP (200^500 cpm/pmol) and 10 mM MgCl2 (total
volume 100 Wl). Aliquots (10 Wl) were removed at di¡erent intervals,
spotted onto P81 phosphocellulose paper and washed three times in
500 ml 1% phosphoric acid, then with acetone. Incorporation of 32P
into the peptides was determined by counting the dried P81 papers in
a scintillation counter. Alternatively, 10 Wl aliquots were added to an
equal volume of SDS^PAGE sample bu¡er, boiled for 5 min and the
samples were electrophoresed on 10% (for proteins) or 20% (for pep-
tides) SDS^PAGE mini-gels. The gels were dried and subjected to
autoradiography to verify incorporation of 32Pi into relevant proteins
or peptides.
2.4. Puri¢cation of phosphorylated MYPT1 peptides
One volume of 30% acetic acid was added to the peptide phosphor-
ylation medium (100 Wl) and the mixture was loaded on a 1 ml Q-
Sepharose Fast Flow column equilibrated with 30% acetic acid [27].
The column was eluted with 30% acetic acid and 0.5 ml fractions were
collected. The majority of the peptide was eluted in the third fraction
as judged by protein assays as well as by radioactivity determination.
Chelate-Sepharose Fast Flow (0.5 ml) was charged with 2.5 ml 20 mM
FeCl3 and washed sequentially with 4 ml distilled water, 3 ml 0.5 M
NH4HCO3 (pH 8.0) and 3 ml distilled water followed by equilibration
with 50 mM MES (pH 5.5) plus 1 M NaCl. The peptide fraction was
loaded on the chelate-Sepharose column, the column was washed with
2.5 ml 50 mM MES (pH 5.5) plus 1 M NaCl, then with 2.5 ml 20 mM
MES (pH 6.0) and the phosphorylated peptides were eluted with 2.5
ml 0.5 M NH4HCO3 (pH 8.0). The eluted fractions (500 Wl each) were
dried in a Speed-Vac apparatus and dissolved in 100 Wl distilled water.
This procedure (drying^dissolving) was repeated three times and the
dried sample was redissolved in the appropriate assay bu¡er.
2.5. Phosphatase assays
Protein phosphatase activity was assayed with 10 WM
[32P]phosphorylase or 5 WM [32P]MLC20 at 30‡C as described previ-
ously [22,26]. E¡ectors (MYPT1 peptides) were preincubated with
PP1c for 10 min at 30‡C. The reaction was initiated by the addition
of substrate.
2.6. Overlay experiments
For dot blot overlay experiments unphosphorylated or phosphory-
lated MYPT11ÿ296 was spotted on nitrocellulose membrane, then the
membrane was blocked with phosphate-bu¡ered saline (PBS) contain-
ing 5% non-fat dried milk plus 0.1% Tween-20. The blots were devel-
oped with anti-MYPT11ÿ38 or overlaid with either 5 WM P-MLC20 or
2 Wg/ml rPP1cN in PBS containing 0.1% Tween-20. Bound P-MLC20
or bound PP1c was detected by a rabbit polyclonal antibody raised
Fig. 1. A: Time course of phosphorylation of N-terminal MYPT1
fragments by PKC. 10 WM of MYPT11ÿ38 (b), MYPT123ÿ38 (R),
MYPT11ÿ34 (S) and MYPT11ÿ296 (F) were incubated with PKC at
30‡C and the extent of phosphorylation was determined as de-
scribed in Section 2. The data represent the average of two deter-
minations each carried out in duplicate. B: Phosphoamino acid
analysis of phosphorylated MYPT11ÿ38 : PS, phosphoserine; PT,
phosphothreonine; PY, phosphotyrosine. C: Autoradiograms of
dried SDS gels of MYPT11ÿ296 (2 WM) phosphorylated by PKC for
120 min in the absence (a) or presence (b) of 2 WM rPP1cN plus
2 WM MC-LR.
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against smooth muscle MLC20 [28] or by a rabbit polyclonal anti-
body speci¢c for the C-terminal peptide of PP1cN [26]. Horseradish
peroxidase-labeled anti-rabbit secondary antibody and enhanced
chemiluminescence were used to detect bound primary antibodies.
2.7. Other procedures
Phosphoamino acid analysis was carried out as described [28]. Pro-
tein concentrations were determined with either the BCA (Pierce) or
Bradford (BioRad) methods using bovine serum albumin as standard.
3. Results
3.1. Phosphorylation of MYPT1 peptides by PKC
Preliminary experiments suggested that both PKC and the
catalytic subunit of cAMP-dependent protein kinase (PKA)
could phosphorylate the N-terminal peptides of MYPT1.
However, PKC appeared to be more e¡ective and was used
in this study. Fig. 1A shows the time course of phosphoryla-
tion of MYPT1 peptides by PKC. MYPT11ÿ38 and
MYPT123ÿ38 were phosphorylated to 1 mol phosphate/mol
peptide. In contrast, the extent of MYPT11ÿ34 phosphoryla-
tion (including Ser-20, Thr-22 and Thr-34 as possible phos-
phorylation sites) was low. Phosphoamino acid analysis iden-
ti¢ed phosphothreonine in phosphorylated MYPT11ÿ38 (Fig.
1B) and MYPT123ÿ38 (results not shown). These data suggest
that the site of phosphorylation is threonine-34, since
MYPT123ÿ38 contains only this phosphorylatable residue.
The low level of phosphorylation in MYPT11ÿ34 may re£ect
a requirement of residue(s) C-terminal of Thr-34 for e¡ective
substrate recognition by PKC. MYPT11ÿ296 was phosphory-
lated by PKC to 2 mol/mol (Fig. 1A) suggesting additional
phosphorylation site(s) in the ankyrin repeat regions (residues
40^296). The autoradiogram in Fig. 1C demonstrates that
MYPT11ÿ296 was phosphorylated to a similar extent in the
absence (1.92 mol/mol) or in the presence (2.05 mol/mol) of
equimolar rPP1cN plus microcystin-LR (MC-LR). Initially,
MC-LR was added to ensure that dephosphorylation of
MYPT11ÿ296 by PP1c did not occur. However, it was later
found that dephosphorylation of phosphorylated MYPT11ÿ38
and MYPT11ÿ296 was not detected over a time course of 120
min at 30‡C. These data suggested that PP1c was not e¡ective
with the phosphorylated peptides and thus the interactions of
the peptides with PP1c could be studied in the absence of
phosphatase inhibitors.
3.2. E¡ect of phosphorylation of the N-terminal MYPT1
peptide on its interaction with PP1c
Thr-34 precedes the consensus PP1c-binding motif of
MYPT1. Phosphorylation of this residue therefore might af-
fect interaction with PP1c. It was shown previously that
MYPT11ÿ38 activated P-MLC20 phosphatase activity of
PP1c [8,16], whereas MYPT123ÿ38 or MYPT11ÿ34 had no ef-
fect [15]. These data suggested that binding of the 35KVKF38
motif initiated interaction of PP1c with residues 1^22 and the
latter resulted in the activation of P-MLC20 activity. Non-
phosphorylated or phosphorylated MYPT11ÿ38 stimulated
the myosin light chain phosphatase activity of PP1c to a sim-
ilar extent (Fig. 2). These data support the conclusion that
phosphorylation of Thr-34 in the N-terminal peptide of
MYPT1 does not a¡ect interaction with PP1c.
3.3. E¡ect of phosphorylation of the ankyrin repeats in
MYPT1 on interactions with PP1c and P-MLC20
The N-terminal region of MYPT1 (residues 1^296) has op-
posite e¡ects on the activity of PP1c with phosphorylase or
P-MLC20 as substrates [7,8,15]. The N-terminal peptides
(MYPT11ÿ38, MYPT11ÿ34 or MYPT123ÿ38) had no e¡ect,
whereas MYPT11ÿ296 inhibited the phosphorylase phospha-
tase activity of PP1c [15]. In contrast, both the N-terminal
peptide (residues 1^38) and the ankyrin repeats (residues 40^
296) contributed to the stimulatory e¡ect of MYPT1 (or N-
terminal MYPT1 mutants) on the P-MLC20 phosphatase ac-
tivity of PP1c [17]. The e¡ects of non-phosphorylated
and phosphorylated MYPT11ÿ296 on the phosphorylase
phosphatase and P-MLC20 phosphatase activities of PP1c
were examined. Fig. 3 indicates that phosphorylated
MYPT11ÿ296 inhibited the phosphorylase phosphatase activity
of PP1c less potently compared to the non-phosphorylated
Fig. 2. E¡ect of non-phosphorylated (a) and phosphorylated (b)
MYPT11ÿ38 on the P-MLC20 phosphatase activity of PP1c. Phos-
phatase activity in the absence of peptides was taken as 100%. Val-
ues are mean þ S.E.M. (n = 4).
Fig. 3. Phosphorylation of the ankyrin repeats by PKC alters the
in£uence of MYPT11ÿ296 on the phosphorylase phosphatase and P-
MLC20 phosphatase activities of PP1c. Phosphorylase phosphatase
(a, b) and P-MLC20 phosphatase (E, F) activities of PP1c were de-
termined in the presence of di¡erent concentrations of non-phos-
phorylated (a, E) or phosphorylated (b, F) MYPT11ÿ296. Phospha-
tase activity in the absence of MYPT11ÿ296 was taken as 100%.
Values are mean þ S.E.M. (n = 3^5).
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peptide. Non-phosphorylated MYPT11ÿ296 stimulated de-
phosphorylation of P-MLC20 by PP1c in a concentration
range from 0.01 to 1 WM. This stimulatory e¡ect was abol-
ished following phosphorylation of MYPT11ÿ296 by PKC.
To examine whether these e¡ects re£ected altered binding
of MYPT11ÿ296 to PP1c and/or P-MLC20 upon
phosphorylation, we carried out dot blot overlay assays.
Non-phosphorylated or phosphorylated MYPT11ÿ296 was
bound to nitrocellulose membrane at di¡erent concentrations
(Fig. 4). The blots were developed with anti-MYPT1 antibody
speci¢c for the N-terminal region, or overlaid with PP1c or
P-MLC20. Binding of the latter proteins to MYPT11ÿ296 was
detected by anti-PP1c and anti-MLC20 antibodies. Overlay
with rPP1cN revealed that less PP1c bound to phosphorylated
than to non-phosphorylated MYPT11ÿ296. A more apparent
di¡erence was observed in the binding of P-MLC20. With
non-phosphorylated MYPT11ÿ296, binding of P-MLC20 was
detected at 0.1 Wg (MYPT fragment), whereas with phosphor-
ylated MYPT11ÿ296, binding was apparent only at a 10-fold
higher concentration. The blot developed using anti-MYPT1
established that similar amounts of non-phosphorylated or
phosphorylated MYPT11ÿ296 were bound to the membrane,
thus the above results probably re£ect di¡erences in the bind-
ing of PP1c or P-MLC20 as a result of phosphorylation of
MYPT11ÿ296.
4. Discussion
Our present data indicate that PKC phosphorylates
MYPT11ÿ296 at Thr-34 and within the ankyrin repeat region
(residues 40^296), although it remains to be established that
phosphorylation occurs at these sites in the phosphatase ho-
loenzyme. Thr-34 is located immediately N-terminal to the
PP1c-binding motif in the MYPT1 sequence and it was of
particular interest to assess how phosphorylation of this res-
idue might a¡ect the interaction of the N-terminal peptide
with PP1c. Recent binding studies using SPR [15] proved
that in MYPT11ÿ38 two regions bind to PP1c: the PP1c-bind-
ing motif (KVKF) corresponding to residues 35^38 plus an N-
terminal sequence located in residues 1^22. Binding of this
latter sequence (residues 1^22) activates the P-MLC20 phos-
phatase activity of PP1c. Kinetic assays with P-MLC20 as
substrate suggested that phosphorylated and non-phosphory-
lated MYPT11ÿ38 did not di¡er in their abilities to bind PP1c
or to stimulate P-MLC20 phosphatase activity of PP1c (see
Fig. 2). These data imply that phosphorylation of Thr-34 had
no in£uence on the interaction with PP1c of either the binding
motif or the binding sequence in residues 1^22. It remains
possible, however, that phosphorylation of Thr-34 in intact
MYPT1 may a¡ect its interaction with PP1c.
Our results are in contrast to ¢ndings regarding the e¡ect of
phosphorylation on the interaction of other targeting subunits
with PP1c. It was shown that phosphorylation of Ser-67 by
PKA within the binding motif of GM [8,16,18] inhibits its
interaction with PP1c. Similar e¡ects were observed when
NIPP1 [19] or neurabin [20] were phosphorylated by PKA
on residues preceding or following the binding motif. Interest-
ingly, the glycogen binding subunit of rat liver also includes a
Ser residue within the PP1c-binding motif, however, this is not
phosphorylated by PKA [29]. In addition, phosphorylation of
Ser-67 in GM complexed with PP1c was not observed suggest-
ing that subunit interactions may also a¡ect the availability of
Ser-67 for phosphorylation [8,16]. MYPT11ÿ296 was also
shown to interact with PP1c and both phosphorylatable re-
gions (residues 1^38 and 40^296) are involved in this interac-
tion [15,17]. However, the interaction with PP1c did not ap-
pear to in£uence the phosphorylation of either region by PKC
(see Fig. 1) suggesting that di¡erences exist between the
phosphorylation characteristics of MYPT1 and the other
PP1c-targeting molecules. It appears that in the PP1c-targeting
proteins the binding motifs represent a general platform for
interaction with PP1c, whereas individual binding pro¢les are
re£ected by di¡erences in the residues £anking the motif and
also in the e¡ects of their phosphorylation.
The ankyrin repeats in MYPT1 represent an important ‘sec-
ondary’ binding site(s) for PP1c. Interaction with PP1c re-
quires the binding motif and those mutants containing the
ankyrin repeats but lacking the motif did not bind to PP1c
[7,15,17]. However, the ankyrin repeat region exhibited facili-
tated binding to PP1c [15] in the presence of the N-terminal
sequences (residues 23^28 or 1^38). Within the ankyrin re-
peats the C-terminal half was e¡ective in increasing inhibition
of phosphorylase phosphatase activity and also this region
was thought to be involved in binding to P-MLC20 [7,8].
The site(s) of phosphorylation by PKC in the ankyrin repeats
was not determined, but a search for PKC consensus phos-
phorylation sites predicted Thr-212 and/or Ser-292 as poten-
tial targets and these are located in the C-terminal half of the
ankyrin repeats. This is consistent with the above observations
that phosphorylation of MYPT11ÿ296 altered its in£uence on
PP1c activities with phosphorylase and P-MLC20 as sub-
strates. Overlay assays indicated that phosphorylation also
decreased the binding of MYPT11ÿ296 to PP1c and this may
underlie the observed enzymatic di¡erences. In addition, over-
lay assays detected a dramatic decrease in the binding of P-
MLC20 to phosphorylated MYPT11ÿ296 and this could also
contribute to the decreased dephosphorylation of this sub-
strate. These data suggest that phosphorylation of the ankyrin
repeats (if it occurs in vivo) might decrease the a⁄nity of MP
Fig. 4. Phosphorylation of MYPT11ÿ296 a¡ects its binding to PP1c
and P-MLC20 as judged by overlay assays. Phosphorylated (P-
MYPT11ÿ296) or non-phosphorylated MYPT11ÿ296 (0.05 to 1 Wg)
was applied to nitrocellulose membrane. After blocking the mem-
brane, the blots were probed with anti-MYPT1 antibody or overlaid
with rPP1cN or P-MLC20 followed by detection of the bound pro-
teins with anti-PP1c or anti-MLC20.
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toward myosin modifying the access of phosphorylated Ser-19
on MLC20 to the catalytic site of PP1c. Phosphorylation at
both locations (i.e. Thr-34 and within the ankyrin repeats)
might be required for inhibition of the stimulatory e¡ect of
MYPT11ÿ296 on P-MLC20 phosphatase activity of PP1c. In
this regard PKC catalyzed phosphorylation of MYPT1 could
be involved in Ca2-sensitization of smooth muscle contrac-
tion [30], although exogenous PKC was shown to have no
stimulatory e¡ect on contraction of demembranated smooth
muscle [30,31], whereas PKC activators triggered Ca2-sensi-
tization of contraction of K-toxin permeabilized smooth
muscle [30]. CPI-17, a 17 kDa cytosolic protein that becomes
a potent inhibitor of PP1 when phosphorylated by PKC [32],
is retained in K-toxin permeabilized, but not in demembra-
nated, smooth muscle [30]. Nevertheless, direct phosphoryla-
tion of MYPT1 by PKC might also decrease activity of MP
toward myosin and contribute to the above e¡ect. It is also
possible that this event is utilized in other cellular functions,
not necessarily involved directly in the contractile mechanism.
In summary, we report here that phosphorylation of the N-
terminal region in MYPT1 can be catalyzed by classical PKC
isoenzymes. Phosphorylation of Thr-34 preceding the PP1c-
binding motif in MYPT1 had no in£uence on the interaction
with PP1c and, in light of opposite ¢ndings with other PP1c-
binding proteins this was an unexpected result. In contrast,
phosphorylation of the ankyrin repeats (in addition to Thr-34)
reduced binding of both PP1c and P-MLC20 to the N-termi-
nal MYPT1 fragment (residues 1^296) suggesting that this
mechanism might be involved in modulation of myosin de-
phosphorylation by PKC or other yet unidenti¢ed protein
kinases.
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